Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients

Back to simplicity: a four-marker blood cell score to quantify prognostically relevant myeloid cells in melanoma patients

Background Myeloid-derived suppressor cells (MDSC), a cornerstone of cancer-related immunosuppression, influence response to therapy and disease outcomes in melanoma patients. Nevertheless, their quantification is far from being integrated into routine clinical practice mostly because of the complex...

Full description

Bibliographic Details
Main Authors: Michele Maio, Lorenza Di Guardo, Veronica Huber, Luca Lalli, Daniele Giardiello, Agata Cova, Paola Squarcina, Paola Frati, Lorenzo Pilla, Marcella Tazzari, Chiara Camisaschi, Flavio Arienti, Chiara Castelli, Valeria Beretta, Licia Rivoltini
Format: Article
Language:English
Published: BMJ Publishing Group 2021-02-01
Series:Journal for ImmunoTherapy of Cancer
Online Access:https://jitc.bmj.com/content/9/2/e001167.full

Internet

https://jitc.bmj.com/content/9/2/e001167.full

Similar Items